Stockreport

IN8bio to Present at Upcoming Investor Conferences

IN8bio, Inc.  (INAB) 
PDF NEW YORK--(BUSINESS WIRE)--IN8bio, Inc. (Nasdaq: INAB), a leading clinical-stage biopharmaceutical company focused on innovative gamma-delta T cell therapies, today [Read more]